(Q46740992)

24 December 2017

title

Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction (English)

1 reference

24 December 2017

author name string

D Hatzichristou

1

1 reference

24 December 2017

M Gambla

2

1 reference

24 December 2017

E Rubio-Aurioles

3

1 reference

24 December 2017

J Buvat

4

1 reference

24 December 2017

G B Brock

5

1 reference

24 December 2017

G Spera

6

1 reference

24 December 2017

L Rose

7

1 reference

24 December 2017

D Lording

8

1 reference

24 December 2017

S Liang

9

1 reference

24 December 2017

publication date

1 February 2008

1 reference

24 December 2017

published in

Diabetic Medicine

1 reference

24 December 2017

volume

25

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

138-146

1 reference

24 December 2017

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

1 reference

Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Predictors and prevalence of erectile dysfunction in a racially diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Prevalence and risk factors for erectile dysfunction in Japanese diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The efficacy and safety of tadalafil: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Erectile dysfunction as a marker for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Vascular risk factors and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Tadalafil pharmacokinetics in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Inflammatory and oxidative markers in atherosclerosis: relationship to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The efficacy of tadalafil in clinical populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Effects of tadalafil on erectile dysfunction in men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Health outcomes variables important to patients in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Phosphodiesterase type 5 inhibitors: the day after

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Is endothelial function impaired in erectile dysfunction patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Erectile and endothelial dysfunction in Type II diabetes: a possible link

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

The effect of vardenafil on endothelial function of brachial and cavernous arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02338.X

10.1111/J.1464-5491.2007.02338.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18290855

1 reference

24 December 2017